BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35421915)

  • 21. Safety and patients' satisfaction after hysteroscopic sterilisation.
    Cabezas-Palacios MN; Jiménez-Caraballo A; Tato-Varela S; Sánchez-Sánchez A; Romero-Díaz C; Carrasco-Gallego A; Zapardiel-Gutiérrez I
    J Obstet Gynaecol; 2018 Apr; 38(3):377-381. PubMed ID: 29046105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Techniques for removal of the Essure hysteroscopic tubal occlusion device.
    Lannon BM; Lee SY
    Fertil Steril; 2007 Aug; 88(2):497.e13-4. PubMed ID: 17397840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation.
    Hopkins MR; Creedon DJ; Wagie AE; Williams AR; Famuyide AO
    J Minim Invasive Gynecol; 2007; 14(1):97-102. PubMed ID: 17218238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can laparoscopic removal of Essure device before embryo transfer correct poor reproductive outcome pattern in IVF? A case report.
    Salem SA; Peck AC; Salem RD; Sills ES
    Clin Exp Obstet Gynecol; 2014; 41(2):219-22. PubMed ID: 24779258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Technique for Essure Reversal.
    Clark NV; Einarsson JI
    JSLS; 2019; 23(1):. PubMed ID: 30846897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASIA (Shoenfeld's syndrome) due to hysteroscopic Essure sterilization.
    Chauhan U; Cassidy B; Cohen Tervaert JW
    Autoimmun Rev; 2021 Dec; 20(12):102979. PubMed ID: 34752966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
    Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
    J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essure® and chronic pelvic pain: a population-based cohort.
    Arjona Berral JE; Rodríguez Jiménez B; Velasco Sánchez E; Povedano Cañizares B; Monserrat Jordan J; Lorente Gonzalez J; Castelo-Branco C
    J Obstet Gynaecol; 2014 Nov; 34(8):712-3. PubMed ID: 24910944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients.
    Ozgur K; Bulut H; Berkkanoglu M; Coetzee K; Kaya G
    Reprod Biomed Online; 2014 Jul; 29(1):113-8. PubMed ID: 24813749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging findings in Essure-related complications: a pictorial review.
    Djeffal H; Blouet M; Pizzoferato AC; Vardon D; Belloy F; Pelage JP
    Br J Radiol; 2018 Oct; 91(1090):20170686. PubMed ID: 29927633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Negative Patient Experiences with Essure Sterilization.
    van Limburg Stirum EVJ; Clark NV; Lindsey A; Gu X; Thurkow AL; Einarsson JI; Cohen SL
    JSLS; 2020; 24(1):. PubMed ID: 32206011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two Surgical Techniques for Essure Device Ablation: The Hysteroscopic Way and the Laparoscopic Way by Salpingectomy with Tubal Interstitial Resection.
    Tissot M; Petry S; Lecointre L; Faller E; Baldauf JJ; Akladios C; Boisrame T
    J Minim Invasive Gynecol; 2019; 26(4):603. PubMed ID: 30064007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of metal elements from the Essure implant: A prospective cohort study.
    Parant F; Bost M; Nohuz E; Prost J; Cerruto E; Moret S; Maurin J; Chene G
    Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():20-25. PubMed ID: 35447464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essure Surgical Removal and Subsequent Resolution of Chronic Pelvic Pain: A Case Report and Review of the Literature.
    Lora Alcantara I; Rezai S; Kirby C; Chadee A; Henderson CE; Elmadjian M
    Case Rep Obstet Gynecol; 2016; 2016():6961202. PubMed ID: 26904330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis comparing the essure tubal sterilization procedure and laparoscopic tubal sterilization.
    Thiel JA; Carson GD
    J Obstet Gynaecol Can; 2008 Jul; 30(7):581-585. PubMed ID: 18644179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation.
    Duffy S; Marsh F; Rogerson L; Hudson H; Cooper K; Jack S; Hunter D; Philips G
    BJOG; 2005 Nov; 112(11):1522-8. PubMed ID: 16225573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tubal perforation by Essure: three different clinical presentations.
    Langenveld J; Veersema S; Bongers MY; Koks CA
    Fertil Steril; 2008 Nov; 90(5):2011.e5-10. PubMed ID: 18692813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How I do… laparoscopic removal of Essure
    Chene G; Vidican P; Azzi C; Carval KL; Chabert P; Beaufils E; Mellier G; Lamblin G
    Gynecol Obstet Fertil Senol; 2017 May; 45(5):316-319. PubMed ID: 28461235
    [No Abstract]   [Full Text] [Related]  

  • 39. Hysteroscopic Sterilization Device Follow-Up Rate: Hysterosalpingogram Versus Transvaginal Ultrasound.
    Jeirath N; Basinski CM; Hammond MA
    J Minim Invasive Gynecol; 2018; 25(5):836-841. PubMed ID: 29289623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study.
    Chudnoff SG; Nichols JE; Levie M
    J Minim Invasive Gynecol; 2015; 22(6):951-60. PubMed ID: 25917278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.